Machine-assisted Spanish translation is in progress. This page is shown in English pending professional review.

Catalog

Two catalogs, one manufacturing site.

Active pharmaceutical ingredients and the finished formulations built from them, manufactured from a single Boisar, Maharashtra site. Choose a catalog below.

API Products · Formulations · manufactured at MIDC Tarapur, Boisar

API Products Active pharmaceutical ingredients (API) 63 ingredients Oncology, Lyophilized Bulk Sterile, and General APIs, read by regulatory filing — DMF and CEP — not export tiers. Browse API catalog → Formulations Finished dosage forms 3 categories Anti-neoplastic, anesthesia, and general formulations, including lyophilized and liquid injectable vials. Dossiers available to partners on request. Browse Formulations →

API Products

Active pharmaceutical ingredients

Mac-Chem's API catalog spans three segments: oncology, lyophilized bulk sterile, and general APIs. Each ingredient is backed by DMF and CEP dossiers, and is read by its regulatory filing rather than by a finished-goods export tier. The full catalog is searchable at /products/api.

Formulations

Finished dosage forms

Mac-Chem's formulations catalog spans three categories: anti-neoplastic, anesthesia, and general. This is a finished-dosage capability, including lyophilized and liquid injectable vials, and dossiers are available to partners on request rather than published as a SKU list. The full catalog is searchable at /products/formulations.

Dossiers, not specs

No specs published here: request a dossier instead

This catalog page and the two searchable indexes it links to list what Mac-Chem manufactures; they do not publish technical specifications, stability data, or CoAs. Every listing routes through an enquiry: submit a product and market, and the regulatory team responds with current dossier status and next steps. This keeps commercially and regulatorily sensitive detail off the public site while still making the full catalog searchable.

Pending approval Dossier status shown per product in the catalog index is drawn from internal dossier tracking and has not been independently reconciled against each national regulator's public register. Treat it as a starting point for enquiry, not a filing guarantee.